Routine clinical application of the lymphocyte fluorescence polarization test for malignant disease.
The technique of Lymphocyte Fluorescence Polarization (LFP) can confirm or exclude the presence of malignant disease. The results from tests on a total of 566 subjects showed a false-positive rate of 3.8% and a false-negative rate of 2.2%. The LFP test has been used as an aid in the differential diagnosis of patients whose symptoms are not typical of primary or recurrent malignant disease. In over 40 such cases there has been total agreement between the LFP results and subsequent clinical or pathological investigations. The LFP Test has been used to monitor the response of cancer patients to various therapeutic regimes. Ovarian cancer patients giving negative LFP results after treatment with Cisplatin have been found free of disease at laparotomy, indicating that LFP may be an acceptable alternative to the surgical investigation. The LFP test has been shown to provide information of much value in the management of patients with malignant disease.
Bater
A J
AJ
Cancer Immunology Section, South Wales Radiotherapy and Oncology Service, Velindre Hospital, Whitchurch, Cardiff, U.K.
Siddall
J E
JE
Pritchard
J A
JA
Kerby
I J
IJ
D000328:Adult; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis*; D019411:Clinical Laboratory Techniques; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis*; D008214:Lymphocytes / Q000166:cytology*; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis*; D012016:Reference Values